These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29016454)

  • 1. INTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION.
    Sudhalkar A; Kodjikian L; Chhablani J; Bhojwani D; Vasavada A
    Retina; 2018 Dec; 38(12):2343-2349. PubMed ID: 29016454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.
    Rezkallah A; Mathis T; Abukhashabah A; Voirin N; Malclès A; Agard É; Lereuil T; Denis P; Dot C; Kodjikian L
    Retina; 2021 Jul; 41(7):1438-1445. PubMed ID: 33315814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension.
    Malclès A; Dot C; Voirin N; Vié AL; Agard É; Bellocq D; Denis P; Kodjikian L
    Retina; 2017 Jul; 37(7):1352-1359. PubMed ID: 27768641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
    Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
    Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT.
    Chin EK; Almeida DRP; Velez G; Xu K; Peraire M; Corbella M; Elshatory YM; Kwon YH; Gehrs KM; Boldt HC; Sohn EH; Russell SR; Folk JC; Mahajan VB
    Retina; 2017 Jul; 37(7):1345-1351. PubMed ID: 27806001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
    Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
    Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
    Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
    Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex®) on intraocular pressure in patients with macular edema.
    Mazzarella S; Mateo C; Freixes S; Burés-Jelstrup A; Rios J; Navarro R; García-Arumí J; Corcóstegui B; Arrondo E
    Ophthalmic Res; 2015; 54(3):143-9. PubMed ID: 26394206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice.
    Hemarat K; Kemmer JD; Porco TC; Eaton AM; Khurana RN; Stewart JM
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):680-685. PubMed ID: 30222802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
    Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
    J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XEN Gel Stent to Treat Intraocular Hypertension After Dexamethasone-Implant Intravitreal Injections: 5 Cases.
    Rezkallah A; Mathis T; Denis P; Kodjikian L
    J Glaucoma; 2019 Jan; 28(1):e5-e9. PubMed ID: 30234749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis.
    Tomkins-Netzer O; Taylor SR; Bar A; Lula A; Yaganti S; Talat L; Lightman S
    Ophthalmology; 2014 Aug; 121(8):1649-54. PubMed ID: 24650556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY.
    Maturi RK; Pollack A; Uy HS; Varano M; Gomes AM; Li XY; Cui H; Lou J; Hashad Y; Whitcup SM;
    Retina; 2016 Jun; 36(6):1143-52. PubMed ID: 26871523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience.
    Monsellato R; Trovato E; Turchetti P; Forestiere M; Pistone A; De Sio S; Accetta L; Pacella F
    Clin Ter; 2020; 170(1):e11-e14. PubMed ID: 31850478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factors.
    Rezkallah A; Kodjikian L; Malclès A; Dot C
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):219-220. PubMed ID: 28801709
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.